New schizophrenia drug LB-102 moves to large safety trial
NCT ID NCT07369154
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This study is testing the long-term safety of a new medication called LB-102 for adults with stable schizophrenia. About 900 participants will take the drug for 52 weeks to see what side effects occur. The goal is to make sure the drug is safe enough for ongoing use to control schizophrenia symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Accelerated Clinical Trial
RECRUITINGSnellville, Georgia, 30078, United States
-
Adams Clinical
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Adams Clinical
RECRUITINGDeSoto, Texas, 75115, United States
-
Advanced Research Center
RECRUITINGAnaheim, California, 92805, United States
-
Arch Clinical Trials
RECRUITINGSt Louis, Missouri, 63141, United States
-
CenExel
RECRUITINGCulver City, California, 92845, United States
-
CenExel
RECRUITINGHollywood, Florida, 33024, United States
-
CenExel
RECRUITINGAtlanta, Georgia, 30331, United States
-
CenExel Gaithersburg
RECRUITINGGaithersburg, Maryland, 20877, United States
-
Chandler Clinical Trials
RECRUITINGChandler, Arizona, 85224, United States
-
Health Synergy Clinical Research
RECRUITINGWest Palm Beach, Florida, 33407, United States
-
Neuro-Behavioral Clinical Research
RECRUITINGNew York, New York, 11516, United States
-
Neuro-Behavioral Clinical Research
RECRUITINGCanton, Ohio, 44720, United States
-
Pillar Clinical Research
RECRUITINGBentonville, Arkansas, 72712, United States
-
Pillar Clinical Research
RECRUITINGLittle Rock, Arkansas, 72204, United States
-
Pillar Clinical Research
RECRUITINGChicago, Illinois, 60641, United States
-
Pillar Clinical Research
RECRUITINGRichardson, Texas, 75080, United States
Contact Email: •••••@•••••
-
ProScience Research Group
RECRUITINGCulver City, California, 90230, United States
-
Redbird Research
RECRUITINGLas Vegas, Nevada, 89119, United States
-
Segal Trials
RECRUITINGMiami Lakes, Florida, 33063, United States
-
Synapse Clinical Trials
RECRUITINGCerritos, California, 90703, United States
-
Synergy San Diego
RECRUITINGSan Diego, California, 92064, United States
-
Woodland International Research Group
RECRUITINGLittle Rock, Arkansas, 72211, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?